JP2008509672A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509672A5
JP2008509672A5 JP2007525816A JP2007525816A JP2008509672A5 JP 2008509672 A5 JP2008509672 A5 JP 2008509672A5 JP 2007525816 A JP2007525816 A JP 2007525816A JP 2007525816 A JP2007525816 A JP 2007525816A JP 2008509672 A5 JP2008509672 A5 JP 2008509672A5
Authority
JP
Japan
Prior art keywords
tshr
mrna
nucleic acid
acid sample
segment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007525816A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509672A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/028688 external-priority patent/WO2006020837A2/en
Publication of JP2008509672A publication Critical patent/JP2008509672A/ja
Publication of JP2008509672A5 publication Critical patent/JP2008509672A5/ja
Pending legal-status Critical Current

Links

JP2007525816A 2004-08-11 2005-08-11 甲状腺癌の検出方法 Pending JP2008509672A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60058904P 2004-08-11 2004-08-11
PCT/US2005/028688 WO2006020837A2 (en) 2004-08-11 2005-08-11 Method of detecting thyroid cancer

Publications (2)

Publication Number Publication Date
JP2008509672A JP2008509672A (ja) 2008-04-03
JP2008509672A5 true JP2008509672A5 (https=) 2008-09-04

Family

ID=35908168

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007525816A Pending JP2008509672A (ja) 2004-08-11 2005-08-11 甲状腺癌の検出方法

Country Status (8)

Country Link
US (1) US20070065833A1 (https=)
EP (1) EP1778872A2 (https=)
JP (1) JP2008509672A (https=)
KR (1) KR20070044048A (https=)
AU (2) AU2005272696A1 (https=)
BR (1) BRPI0514265A (https=)
CA (1) CA2576912A1 (https=)
WO (1) WO2006020837A2 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338109B2 (en) 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
US8394580B2 (en) * 2007-08-17 2013-03-12 The Johns Hopkins University Protein markers for the detection of thyroid cancer metastasis
EP2806054A1 (en) 2008-05-28 2014-11-26 Genomedx Biosciences Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
WO2010056374A2 (en) 2008-11-17 2010-05-20 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
US8669057B2 (en) 2009-05-07 2014-03-11 Veracyte, Inc. Methods and compositions for diagnosis of thyroid conditions
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
US20110312520A1 (en) 2010-05-11 2011-12-22 Veracyte, Inc. Methods and compositions for diagnosing conditions
US20130267443A1 (en) 2010-11-19 2013-10-10 The Regents Of The University Of Michigan ncRNA AND USES THEREOF
EP2791359B1 (en) 2011-12-13 2020-01-15 Decipher Biosciences, Inc. Cancer diagnostics using non-coding transcripts
DK3435084T3 (da) 2012-08-16 2023-05-30 Mayo Found Medical Education & Res Prostatakræftprognose under anvendelse af biomarkører
WO2014151764A2 (en) 2013-03-15 2014-09-25 Veracyte, Inc. Methods and compositions for classification of samples
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
EP3215170A4 (en) 2014-11-05 2018-04-25 Veracyte, Inc. Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
US10654934B2 (en) 2016-04-01 2020-05-19 Innovative Cellular Therapeutics CO., LTD. Use of chimeric antigen receptor modified cells to treat cancer
CN109219445B (zh) * 2016-04-01 2022-08-26 上海煦顼技术有限公司 嵌合抗原受体修饰细胞治疗癌症的应用
EP3504348B1 (en) 2016-08-24 2022-12-14 Decipher Biosciences, Inc. Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
EP3571322B9 (en) 2017-01-20 2023-10-04 VERACYTE SD, Inc. Molecular subtyping, prognosis, and treatment of bladder cancer
EP3593140A4 (en) 2017-03-09 2021-01-06 Decipher Biosciences, Inc. SUBTYPING PROSTATE CANCER TO PREDICT RESPONSE TO HORMONE THERAPY
CA3062716A1 (en) 2017-05-12 2018-11-15 Decipher Biosciences, Inc. Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
WO2019028285A2 (en) 2017-08-04 2019-02-07 Genomedx, Inc. USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY
CN108089011A (zh) * 2018-01-09 2018-05-29 广州市康润生物科技有限公司 一种快速免疫检测系统在手术中的新用途
KR102526916B1 (ko) * 2019-04-05 2023-05-02 주식회사 제놉시 Cfdna를 이용한 위암 진단방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391579B1 (en) * 1996-02-01 2002-05-21 Albert Einstein College Of Medicine Of Yeshiva University Thyroid sodium/iodide symporter and nucleic acid encoding same
US6066449A (en) * 1997-04-15 2000-05-23 The Trustees Of Columbia University In The City Of New York Method of detecting metastatic thyroid cancer
AU7830598A (en) * 1997-06-10 1998-12-30 Michael A. Levine Methods for thyroid cell detection
US20020009778A1 (en) * 1998-05-29 2002-01-24 Incyte Pharmaceuticals, Inc. Thyroid and pituitary membrane protein
US6436642B1 (en) * 1999-04-20 2002-08-20 Curagen Corporation Method of classifying a thyroid carcinoma using differential gene expression

Similar Documents

Publication Publication Date Title
JP2008509672A5 (https=)
Carrascosa et al. Molecular inversion probe-based SPR biosensing for specific, label-free and real-time detection of regional DNA methylation
Johnson et al. Sample preparation-free, real-time detection of microRNA in human serum using piezoelectric cantilever biosensors at attomole level
JP2007536260A5 (https=)
Duan et al. An ssDNA library immobilized SELEX technique for selection of an aptamer against ractopamine
JP2009536525A5 (https=)
JP2010532986A5 (https=)
JP2010528618A5 (https=)
JP2008245635A5 (https=)
WO2006050499A3 (en) Single step detection assay
JP2009509508A5 (https=)
JP2010535219A5 (https=)
JP2009077712A5 (https=)
JP2008249727A5 (https=)
DK1370683T3 (da) mRNA-amplifikation
Giamblanco et al. Single-step label-free hepatitis B virus detection by a piezoelectric biosensor
JP2012513216A5 (https=)
JP2016505268A (ja) バイオマーカーとしてのmiRNA−124
JP2019520802A5 (https=)
Xie et al. CRISPR-Cas12a coupled with DNA nanosheet-amplified fluorescence anisotropy for sensitive detection of biomolecules
ATE360708T1 (de) Test-streife-probesystem und verfahren zur nachweis von spezifischen nukleinsäuresequenzen
WO2009057829A3 (en) Nucleic acid primer set for detection of drug-resistant strain of hepatitis b virus, assay kit, and method of detecting drug-resistant strain of hepatitis b virus
WO2009074882A3 (en) One-step target detection assay using a tagged and blocked target-specific pcr primer and an anti-tag capture complex
WO2008117782A1 (ja) 遺伝子増幅用プライマーセット、それを含む遺伝子増幅用試薬およびその用途
JP2009518001A5 (https=)